Executive order to raise drug price transparency is signed by DeSantis
"I think it's going to be very, very meaningful."
Gov.
Gov.
The point of the executive order is to ultimately lower the price of prescription drugs. DeSantis said. He said that with the rise in food and gas costs, addressing the price of pharmaceuticals is one area he could "make a difference."
"This executive order is really probably the first time
The order would help make pharmacy benefit managers, third-party administrators of prescription drug programs, accountable when managing prescription drug benefits for insurance companies.
"
The order directs all executive agencies to include the following in all future contracts with PBMs:
Prohibit spread pricing
Prohibit reimbursement claw backs
Include data transparency and reporting requirements
Review all rebates, payments and relationships between pharmacies, insurers and manufacturers
Amend all current contracts they can with the same provisions
In a news release sent Friday, Jackson applauded DeSantis on the executive order.
"We are encouraged by this latest development – which follows the passage of House Bill 357 — and the governor's continued commitment on this critical issue facing so many Floridians and their families," Jackson said.
House Bill 357, which went into effect
"We're going to use the executive order as our baseline and we're going to look for more ways to ensure that we are saving taxpayers money and we are ensuring that independent and small pharmacies can serve not only the Medicaid population, but all members of this community without going out of business at the hands of PBMs."
The biggest hurdle though, according to DeSantis and Marstiller, is the
The executive order isn't the only thing the state has done to try and lower prescription drug prices, according to DeSantis. The state's Canadian Prescription Drug Importation Program has been under review by the FDA for nearly 600 days.
This program, if approved, would allow prescriptions drugs to be imported to
ACHA filed a Freedom of Information Act to find out why the program has been stalled.
DeSantis pointed out that while the FDA was quick to approve COVID-19 vaccines for children, and the import of baby formula, the agency has taken its time when it comes to
"It's interesting when you look at the FDA dragging their feet on what we're trying to do, which is buy cheaper drugs," DeSantis said.
"I think it's going to be very, very meaningful."
Gov.


Louisiana Extends Ida Mediation Program Through End of 2022
Musk abandons deal to buy Twitter; company says it will sue
Advisor News
- After the midterms: Addressing your clients’ tax concerns
- Berkeley arts tax heads toward passage while public bank measure looks likely to fail
- Americans’ sense of overall prosperity still ticks upward
- Turning expanded eligibility into a better coverage plan for federal clients
- Election 2026: Which of Berkeley's 7 ballot measures will pass?
More Advisor NewsAnnuity News
- AM Best Affirms Credit Ratings of Knighthead Annuity & Life Assurance Company and Merit Life Insurance Co.
- Jackson reports record annuity sales, increases share repurchase authorization
- Why the market doesn’t need more carriers
- Equitable, Corebridge steam toward merger with strong Q3 annuity sales
- Jackson Announces New Annuity Offering for AARP Members
More Annuity NewsHealth/Employee Benefits News
- New Congress must address drug affordability
- AM Best Upgrades Issuer Credit and National Scale Ratings of Auna Seguros, S.A.
- MAKE AMERICA HEALTHY AGAIN MEETS PUBLIC CHOICE
- Genworth reports loss of $41M in CEO Tom McInerney’s final earnings
- Kansas Silver Haired Legislature renews call for Medicaid expansion
More Health/Employee Benefits NewsLife Insurance News
- National Life Group Approves $23 Million Dividends for 2027
- Milliman’s proposed $15.5 million settlement puts life insurance underwriting data in focus
- Brighthouse Financial Announces Third Quarter 2026 Results
- Prudential earnings dip as Japan sales suspension offsets U.S. growth
- U-Haul Holding Company Reports Second Quarter Fiscal 2027 Financial Results
More Life Insurance News